Guidelines & Consensus
Malignancy Surveillance in Common Variable Immunodeficiency: Expert Delphi Consensus Guidelines
Cabanero-Navalon et alFrontiers in immunology
A multidisciplinary Spanish Delphi consensus study involving 39 experts across 22 adult and pediatric hospital centers developed standardized recommendations for cancer screening and surveillance in common variable immunodeficiency (CVID). CVID represents the most common symptomatic adult inborn error of immunity, with malignancy—specifically hematological neoplasms and gastric carcinoma—occurring in up to 15% of patients in registry data and accounting for significant morbidity and mortality.
To reduce clinical variability, the panel evaluated 87 statements across four domains: epidemiology/risk factors, solid tumors, hematological malignancies, and immunological biomarkers using a two-round Delphi process, defining consensus as ≥70% agreement or disagreement. Overall, consensus was reached on 80.5% (70 of 87) of the proposed statements.
For immunological baseline and solid tumor monitoring in adults, the expert consensus recommends baseline genetic testing, annual immunophenotyping to track malignancy risk markers, baseline upper gastrointestinal endoscopy with histology-guided follow-up, annual Helicobacter pylori testing, and regular monitoring of micronutrients and pernicious anemia-related antibodies. Hematological surveillance recommendations include systematic physical and imaging evaluation of lymphadenopathy (with biopsy when indicated), CT imaging for unexplained weight loss, and bone marrow evaluation for cytopenias lasting longer than 6 months. Finally, the panel emphasized that pediatric surveillance should remain individualized and age-adapted rather than directly applying adult screening frameworks.
Key Takeaways
- A 39-expert Delphi panel reached consensus (≥70% agreement) on 80.5% (70/87) of statements, establishing guidelines that recommend systematic genetic testing at diagnosis, annual immunophenotyping, baseline upper gastrointestinal endoscopy, and annual Helicobacter pylori testing in adults with CVID.
- Hematological surveillance recommendations dictate systematic evaluation of lymphadenopathy (imaging ± biopsy), CT imaging for unexplained weight loss, and bone marrow aspirate or biopsy for cytopenias persisting beyond 6 months.
- Pediatric CVID malignancy management requires individualized, age-adapted protocols and explicitly cautions against direct extrapolation from adult screening strategies.
Read the original sourceFrontiers in immunology
